From Plants to Wound Dressing and Transdermal Delivery of Bioactive Compounds DOI Creative Commons
Gabriela Isopencu,

Cristina-Ileana Covaliu-Mierlă,

Iuliana Mihaela Deleanu

и другие.

Plants, Год журнала: 2023, Номер 12(14), С. 2661 - 2661

Опубликована: Июль 16, 2023

Transdermal delivery devices and wound dressing materials are constantly improved upgraded with the aim of enhancing their beneficial effects, biocompatibility, biodegradability, cost effectiveness. Therefore, researchers in field have shown an increasing interest using natural compounds as constituents for such systems. Plants, important source so-called “natural products” enormous variety structural diversity that still exceeds capacity present-day sciences to define or even discover them, been part medicine since ancient times. However, benefits just at beginning being fully exploited modern dermal transdermal Thus, plant-based primary compounds, without biological activity, contained gums mucilages, traditionally used gelling texturing agents food industry, now explored valuable cost-effective components biomedical field. Their non-toxicity compensate local availability compositional variations. Also, secondary metabolites, classified based on chemical structure, intensively investigated wide pharmacological toxicological effects. impact is highlighted detail through most recent reported studies. Innovative isolation purification techniques, new drug systems, advanced evaluation procedures presented.

Язык: Английский

Wild grown Portulaca oleracea as a novel magnetite based carrier with in vitro antioxidant and cytotoxicity potential DOI Creative Commons
Adina‐Elena Segneanu, Gabriela Vlase, C.N. Marin

и другие.

Scientific Reports, Год журнала: 2025, Номер 15(1)

Опубликована: Март 13, 2025

The latest research on nanotechnology through the new tailored scaffolds encompassed therapeutic effects of natural compounds, and unique properties metallic nanoparticles offer possibilities in emerging biomedical fields. Various strategies have been developed to address limitations existing agents concerning specificity, vectorization, bioavailability, drug resistance, adverse effects. In this study, medicinal plant Portulaca oleracea L. magnetite were used develop an innovative target carrier system, designed enhance cytotoxic effect overcome main drawbacks (permeability localization) phytoconstituents. low-metabolite profile Romanian wild-grown exhibits a diverse range hundred fifty-five compounds across various chemical categories (amino acids, peptides, fatty flavonoids, alkaloids, terpenoids, phenolic organic esters, sterols, coumarins, nucleosides, lignans, miscellaneous compounds). Morpho-structural magnetic phytocarrier investigated using variety methods, including XRD, FTIR, Raman, SEM, DLS), determinations. MTT assay was conducted evaluate vitro potential cytotoxicity normal human dermal fibroblasts (NHDF), as well two tumoral cell lines: osteosarcoma (HOS) cervical cancer (HeLa). Results indicated that significant inhibition both lines' viability exerted by compared herbal extract. Furthermore, results obtained for total content antioxidant screening performed FRAP DPPH assays superior system. These findings suggest applications system its promising implications future development field.

Язык: Английский

Процитировано

1

Mechanistic Study of Cancer Drug Delivery: Current Techniques, Limitations, and Future Prospects DOI Creative Commons

Saiqa Imtiaz,

Umme Tamanna Ferdous,

Alexis Nizela

и другие.

European Journal of Medicinal Chemistry, Год журнала: 2025, Номер 290, С. 117535 - 117535

Опубликована: Март 20, 2025

Cancer drug delivery remains a critical challenge with systemic toxicity, poor bioavailability, and lack of effective targeting. Overcoming these barriers is essential for improving treatment efficacy patient outcomes. This review discusses current techniques that reshape cancer therapy by offering precise, controlled-release tailored to tumor-specific features. Innovations in nanotechnology, immunotherapy, gene enable interventions at molecular cellular levels. Radiomics pathomics integrate high-dimensional data optimize diagnostics planning. Combination addresses the complexities tumor heterogeneity synergizing multiple agents within single therapeutic framework, while peptide-drug conjugates enhance specificity potency. Hydrogel-based systems microneedle arrays offer localized, sustained release, significantly However, clinical translation advancements faces significant such as resistance, off-target effects, scalability, cost, ethical concerns. Moreover, regulatory economic feasibility therapies highlight need innovative frameworks make them accessible globally. Therefore, there innovation cell therapy, next-generation platforms, personalized medicine. focuses on recent over past decade, evaluating their limitations exploring potential future directions transforming treatment.

Язык: Английский

Процитировано

1

Fabrication and characterization of bee pollen extract nanoparticles: Their potential in combination therapy against human A549 lung cancer cells DOI Creative Commons
Nemany A.N. Hanafy, Elsayed I. Salim,

Magdy E. Mahfouz

и другие.

Food Hydrocolloids for Health, Год журнала: 2022, Номер 3, С. 100110 - 100110

Опубликована: Дек. 9, 2022

Bee pollen extract (BPE) based polymer nanoparticles (BPENP) were fabricated in the current study by using bovine serum albumin (BSA) and complex was then coated folic acid conjugated protamine to be targeted for cancer cells. Spectroscopic microscopic methods used characterize resultant nanoparticles. High flavonoid polyphenolic contents detected HPLC. At 336 nm, it found that BPENP provided highest absorption UV. The average particle size ranged between 25 40 nm. inhibitory effects IC50 values of acquired BPE, BPENP, Avastin, or their combination at 24 48 h against A549 lung therapy assay Avastin revealed a very significant synergism two drugs with low index (CI). These therapies particularly have significantly affected expression HRAS, MAPK, apoptotic genes such as Bax, Bcl-2, Caspase 3. It established obtained might employed support administration treatment cancer.

Язык: Английский

Процитировано

26

CD44-Targeted Lipid Polymer Hybrid Nanoparticles Enhance Anti-Breast Cancer Effect of Cordyceps militaris Extracts DOI Creative Commons
Jiraphong Suksiriworapong, Nutthachai Pongprasert, Somnuk Bunsupa

и другие.

Pharmaceutics, Год журнала: 2023, Номер 15(6), С. 1771 - 1771

Опубликована: Июнь 20, 2023

This study aimed to improve the anticancer effect of Cordyceps militaris herbal extract (CME) on breast cancer cells with hyaluronic acid (HYA) surface-decorated lipid polymer hybrid nanoparticles (LPNPs) and evaluate applicability a synthesized poly(glycerol adipate) (PGA) for LPNP preparation. Firstly, cholesterol- vitamin E-grafted PGA polymers (PGA-CH PGA-VE, respectively) were fabricated, without maleimide-ended polyethylene glycol. Subsequently, CME, which contained an active cordycepin equaling 9.89% its weight, was encapsulated in LPNPs. The results revealed that could be used prepare CME-loaded formulations containing Mal-PEG decorated cysteine-grafted HYA via thiol-maleimide reactions. HYA-decorated PGA-based LPNPs substantially enhanced CME against MDA-MB-231 MCF-7 by enhancing cellular uptake through CD44 receptor-mediated endocytosis. demonstrated successful targeted delivery receptors tumor HYA-conjugated new application PGA-CH- PGA-VE-based developed showed promising potential extracts treatment clear translation vivo experiments.

Язык: Английский

Процитировано

15

From Plants to Wound Dressing and Transdermal Delivery of Bioactive Compounds DOI Creative Commons
Gabriela Isopencu,

Cristina-Ileana Covaliu-Mierlă,

Iuliana Mihaela Deleanu

и другие.

Plants, Год журнала: 2023, Номер 12(14), С. 2661 - 2661

Опубликована: Июль 16, 2023

Transdermal delivery devices and wound dressing materials are constantly improved upgraded with the aim of enhancing their beneficial effects, biocompatibility, biodegradability, cost effectiveness. Therefore, researchers in field have shown an increasing interest using natural compounds as constituents for such systems. Plants, important source so-called “natural products” enormous variety structural diversity that still exceeds capacity present-day sciences to define or even discover them, been part medicine since ancient times. However, benefits just at beginning being fully exploited modern dermal transdermal Thus, plant-based primary compounds, without biological activity, contained gums mucilages, traditionally used gelling texturing agents food industry, now explored valuable cost-effective components biomedical field. Their non-toxicity compensate local availability compositional variations. Also, secondary metabolites, classified based on chemical structure, intensively investigated wide pharmacological toxicological effects. impact is highlighted detail through most recent reported studies. Innovative isolation purification techniques, new drug systems, advanced evaluation procedures presented.

Язык: Английский

Процитировано

14